Antibe Therapeutics Price to Book Ratio 2014-2021 | ATBPF
Historical price to book ratio values for Antibe Therapeutics (ATBPF) over the last 10 years. The current price to book ratio for Antibe Therapeutics as of October 26, 2021 is 0.58.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
|Antibe Therapeutics Price/Book Ratio Historical Data
||Book Value per Share
||Price to Book Ratio
||Medical - Biomedical and Genetics
Antibe Therapeutics Inc. is a biotech company with a drug platform of therapeutics in pain and inflammation. Its lead drug candidate consists of ATB-346, non-addictive drug for chronic pain and inflammation; ATB-352, for a non-addictive analgesic for treating severe acute pain, while ATB-340 is a GI-safe derivative of aspirin. Antibe Therapeutics Inc. is based in Toronto, Canada.